Рубрики Mesh:
Пожилые
Лекарственная терапия комбинированная
Человек
Мочевых путей нижних симптомы
Мочевых путей нижних симптомы - терапия
Мужской
Средний возраст
Москва
Проспективные исследования
Предстательной железы гиперплазия
Предстательной железы гиперплазия - терапия
Журнальная статья
Pushkar D.Y. D Yu
Rasner P.I.
Kotenko D.V.
Gerasimov A.N.
Shabalkin S.A.
Department of Urology of A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow, Russia.
Department of Medical informatics and statistics of I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Treatment of patients with lower urinary tract symptoms in Moscow
Текст визуальный электронный
Urologiia (Moscow, Russia : 1999)
№ 3 С. 7-12
2019
-blockers
benign prostatic hyperplasia
lower urinary tract symptoms
Статья
Aged M01.060.116.100
Пожилые M01.060.116.100
Drug Therapy, Combination E02.319.310
Лекарственная терапия комбинированная E02.319.310
Humans B01.050.150.900.649.313.988.400.112.400.400
Человек B01.050.150.900.649.313.988.400.112.400.400
Lower Urinary Tract Symptoms C23.888.942.343
Lower Urinary Tract Symptoms therapy C23.888.942.343
Мочевых путей нижних симптомы C23.888.942.343
Мочевых путей нижних симптомы терапия C23.888.942.343
Male
Мужской
Middle Aged M01.060.116.630
Средний возраст M01.060.116.630
Moscow Z01.433.653 Z01.542.248.775.510
Москва Z01.433.653 Z01.542.248.775.510
Prospective Studies E05.318.372.500.750.625 N05.715.360.330.500.750.650 N06.850.520.450.500.750.650
Проспективные исследования E05.318.372.500.750.625 N05.715.360.330.500.750.650 N06.850.520.450.500.750.650
Prostatic Hyperplasia C12.100.500.565.500 C12.200.294.565.500
Prostatic Hyperplasia therapy C12.100.500.565.500 C12.200.294.565.500
Предстательной железы гиперплазия C12.100.500.565.500 C12.200.294.565.500
Предстательной железы гиперплазия терапия C12.100.500.565.500 C12.200.294.565.500
Journal Article V02.600
Журнальная статья V02.600
In recent years, there has been a persistent tendency to a decrease in surgical treatment of patients with lower urinary symptoms (LUTS). This fact can be explained by variety drugs which have acceptable safety and high efficiency for treatment of urinary disorders. As part of our survey of men in Moscow region, the trends in prescribing the different drugs for the LUTS was studied. In addition, the duration of therapy and patient adherence were analyzed.